Concolino, P.; Gelli, G.; Rizza, R.; Costella, A.; Scambia, G.; Capoluongo, E.
BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants. Int. J. Mol. Sci. 2019, 20, 3442.
https://doi.org/10.3390/ijms20143442
AMA Style
Concolino P, Gelli G, Rizza R, Costella A, Scambia G, Capoluongo E.
BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants. International Journal of Molecular Sciences. 2019; 20(14):3442.
https://doi.org/10.3390/ijms20143442
Chicago/Turabian Style
Concolino, Paola, Gianfranco Gelli, Roberta Rizza, Alessandra Costella, Giovanni Scambia, and Ettore Capoluongo.
2019. "BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants" International Journal of Molecular Sciences 20, no. 14: 3442.
https://doi.org/10.3390/ijms20143442
APA Style
Concolino, P., Gelli, G., Rizza, R., Costella, A., Scambia, G., & Capoluongo, E.
(2019). BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants. International Journal of Molecular Sciences, 20(14), 3442.
https://doi.org/10.3390/ijms20143442